| Purpose | Announcement Date | Split Date | Record Date | Face Value (before split) | Face Value (after split) |
|---|---|---|---|---|---|
| Split | 28 Aug 2024 | 15 Oct 2024 | 15 Oct 2024 | 10 | 2 |
| Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on August 28, 2024. Sub: Face Value Split - Vaishali Pharma Limited (VAISHALI) It is hereby informed that the face value and paid-up value of the equity shares of the following Company shall be changed w.e.f. October 15, 2024 Name of the Company Vaishali Pharma Limited Symbol VAISHALI Existing Face Value & Paid-up Value (Rs. 10 New Face Value & Paid-up Value (Rs.) 2 This circular shall be effective from October 15, 2024. For and on behalf of National Stock Exchange of India Limited (AS Per NSE Notice Dated on 09.10.2024) New ISIN INE972X01022 Remarks Sub-Division from Rs. 10/- to Rs. 2/- For and on behalf of National Stock Exchange of India Limited (As Per NSE Circular Dated on 11.10.2024) | |||||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
